Approval · Notice of Compliance 15751 · 2014
PROPOFLO: Notice of Compliance 15751
Issued June 30, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15751
- Date
- June 30, 2014
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the drug product manufacturing site; addition of oleic acid to the formulation
- Therapeutic class
- Anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFLO | 02244685 | Cancelled Post Market |
Medicinal ingredients
- PROPOFOL 10 MG per ML